Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Pancreatic Neoplasms 5Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Neoplasms by Site 2Multiple Myeloma 2Digestive System Neoplasms 2Digestive System Diseases 2Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Stomatitis 1Rectal Diseases 1Pancreatic Diseases 1Oligodendroglioma 1Neoplasms, Plasma Cell 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Motor Activity 1Lung Neoplasms 1Liver Neoplasms 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Lymphoid 1Intestinal Neoplasms 1Intestinal Diseases 1Inflammation 1Graft vs Host Disease 1Gliosarcoma 1

Interventions

Dexamethasone 277Lenalidomide 155Bortezomib 152Cyclophosphamide 115Melphalan 107Calcium Dobesilate 107fludarabine phosphate 70carfilzomib 61pomalidomide 55Peripheral Blood Stem Cell Transplantation 53Whole-Body Irradiation 52Mycophenolic Acid 52Granulocyte Colony-Stimulating Factor 52Filgrastim 52daratumumab 46fludarabine 43Tacrolimus 41ixazomib 40Busulfan 40Thalidomide 36Cyclosporine 32dexamethasone acetate 26Stem Cell Transplantation 26Antilymphocyte Serum 25dexamethasone 21-phosphate 22plerixafor 20auricularum 20belantamab mafodotin 19Prednisone 19Etoposide 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Multiple Myeloma × Ascorbic Acid × Clear all
NCT00469209 2020-09-24

Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed
60 enrolled 7 charts
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00661544 2013-03-04

Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed
48 enrolled 3 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡